Reveals the DNA of your Ambitions BioExperTeam supports Biotech and Pharma Industry leaders to facilitate innovation and business development. Through... View Article
Author Archives for Adeline Chauvigné
New member | BioExperTeam
11 May 2025Reveals the DNA of your Ambitions BioExperTeam supports Biotech and Pharma Industry leaders to facilitate innovation and business development. Through... View Article
New member | Kalsiom
Targeting calcium signaling to cure auto-immune diseases KALSIOM is a biotech company founded in April 2020 in Brest, France, discovering... View Article
New member | Kalsiom
11 May 2025Targeting calcium signaling to cure auto-immune diseases KALSIOM is a biotech company founded in April 2020 in Brest, France, discovering... View Article
COVID-19 : Cynbiose and VirPath team up in a collaborative R&D project related to the SARS-CoV-2outbreak
Cynbiose in partnership with the academic laboratory VirPath announced today the launch of the COVIBIOSE project. The COVIBIOSE project... View Article
COVID-19 : Cynbiose and VirPath team up in a collaborative R&D project related to the SARS-CoV-2outbreak
11 May 2025Cynbiose in partnership with the academic laboratory VirPath announced today the launch of the COVIBIOSE project. The COVIBIOSE project... View Article
Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer
Saint-Herblain (France), June 8 2020 – Valneva SE (“Valneva” or “the Company”) announced today that the antitrust-related condition precedent for its Lyme vaccine... View Article
Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer
11 May 2025Saint-Herblain (France), June 8 2020 – Valneva SE (“Valneva” or “the Company”) announced today that the antitrust-related condition precedent for its Lyme vaccine... View Article
Valneva Announces Publication in The Lancet of Complete Phase 1 Data for its Single-Shot Chikungunya Vaccine Candidate
Saint-Herblain (France), June 2, 2020 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, announced today the publication of full data... View Article
Valneva Announces Publication in The Lancet of Complete Phase 1 Data for its Single-Shot Chikungunya Vaccine Candidate
11 May 2025Saint-Herblain (France), June 2, 2020 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, announced today the publication of full data... View Article
Covid-19: the French Bioclusters network unveil a national initiative map.
Strasbourg, Paris, Lyon, Lille, Nantes, Marseille, 7th May 2020 – The six health competitiveness clusters – Atlanpole Biotherapies, BioValley France,... View Article
Covid-19: the French Bioclusters network unveil a national initiative map.
11 May 2025Strasbourg, Paris, Lyon, Lille, Nantes, Marseille, 7th May 2020 – The six health competitiveness clusters – Atlanpole Biotherapies, BioValley France,... View Article
New member | Hawkcell
HawkCell is a CRO that provides in vivo MRI services on animals (from 1 to 150kg). We extend the potential... View Article
New member | Hawkcell
11 May 2025HawkCell is a CRO that provides in vivo MRI services on animals (from 1 to 150kg). We extend the potential... View Article
Horama | 3 experts have just joined the team
HORAMA, a clinical stage gene therapy company in ophthalmology, announced several appointments in recent weeks : Rodolphe Clerval has been... View Article
Horama | 3 experts have just joined the team
11 May 2025HORAMA, a clinical stage gene therapy company in ophthalmology, announced several appointments in recent weeks : Rodolphe Clerval has been... View Article
CEBR & COVID-19 | Webinars
CEBR members are key actors in looking for solutions to improve the current COVID situation, locally but also at EU... View Article
CEBR & COVID-19 | Webinars
11 May 2025CEBR members are key actors in looking for solutions to improve the current COVID situation, locally but also at EU... View Article
Xenothera news
XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article
Xenothera news
11 May 2025XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article